Pro-inflammatory cytokine and survival signaling nodes

Pro-inflammatory cytokine and survival signaling nodes refer to a complex network of signaling pathways that integrate external inflammatory stimuli with internal cell survival mechanisms. This network includes key cytokines such as Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-6 (IL-6), along with intracellular mediators like Nuclear Factor-kappa B (NF-κB), Janus Kinases (JAK), and the PI3K/Akt/mTOR pathway (Source: Nature Reviews Drug Discovery [1], PubMed [2]). These nodes are critical for coordinating the immune response and maintaining cellular homeostasis, but their dysregulation is a primary driver of chronic inflammation, autoimmunity, and oncogenesis (Source: NIH [3], StatPearls [4]). In cancer, these pathways often promote tumor growth and resistance to therapy by suppressing apoptosis and enhancing proliferation. Therapeutic targeting of these nodes involves a diverse array of agents, including monoclonal antibodies and small-molecule inhibitors, designed to block specific signaling events (Source: PubMed [5]). However, because these pathways are also essential for normal immune function, their inhibition can lead to significant safety concerns such as systemic immunosuppression and increased infection risk (Source: FDA [6]).

Other names

Pro-inflammatory signaling networkCytokine-mediated survival pathwaysInflammatory signaling nodesSurvival signaling network

Modulation of inflammatory and survival responses through the inhibition of specific cytokines, receptors, or intracellular signaling kinases (e.g., JAK, PI3K, MAPK) and transcription factors (e.g., NF-κB).